Determination of dandelion capsule on patient with Covid-19 virus

Determination of dandelion herbal capsule (Dandelherb) efficacy on symptom of patient with Covid-19 virus: a clinical trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180513039641N2

Enrollment

Registered

2020-07-27

Start date

2020-07-26

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 infectious disease. Coronavirus infection :COVID-19, virus identified (a disease diagnosis of COVID-19 confirmed by laboratory testing)

Interventions

Intervention 1: Intervention group: Oral yellow herbal Dandelion Capsule 300 mg with production license by the Managing Director of Nik Daroie Shafasaz Amiran Company and produced in Booali Daro Pharm

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients Hospitalized in shaheed Beheshti Hospital in Qom with Covid-19 (their PCR test is positive). Patients between 18-65 years. Satisfaction of people to test this drug and its possible side effects.

Exclusion criteria

Exclusion criteria: History of allergy to plants of asteraceae. bile duct and intestinal obstruction. acute cholecystitis, empyema, acute gall bladder inflammation. Gastrointestinal diseases, gastritis, irritable bowel syndrome. Diabetes and kidney failure. Alcohol consumption history (more than 10 grams per day for women and more than 20 grams per day for men). Pregnant and lactating women and Married women who are in childbearing age and do not use reliable contraception method. Weight below 50 kg Uncontrolled underlying diseases such as high blood pressure and .... Consumers of Lithium, digoxin, corticosteroids such as prednisone, niacin / nicotinic acid, metronidazole, disulfiram, tetracycline and fluoroquinolone antibiotics (such as ciprofloxacin), hypoglycemic drugs, antiplatelet drugs, diuretics, Antacids such as famotidine and s omeprazole. Consumers of s bloodroot, cat’s claw, chamomile, chaparral, chasteberry, damiana, Echinacea angustifolia, goldenseal, grapefruit juice, licorice, oregano, redclover,St.John’swort, wildcherry, andyucca.

Design outcomes

Primary

Measure	Time frame
C-Reactive Protein. Timepoint: Measurement of C-Reactive Protein at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;White blood cell. Timepoint: Measurement of white blood cell at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;Red blood cell. Timepoint: Measurement of Red blood cell at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Hemoglobin. Timepoint: Measurement of hemoglobin at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;Albumin. Timepoint: Measurement of Albumin at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Alanine aminotransferase. Timepoint: Measurement of Alanine aminotransferase at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Aspartate transaminase. Timepoint: Measurement of Aspartate transaminase at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Creatinine. Timepoint: Measurement of Creatinine at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Blood Urea Nitrogen. Timepoint: Measurement of Blood Urea Nitrogen at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Total Bilirubin. Timepoint: Measurement of Total Bilirubin at the beginning of the study (before the start of the study) and 40 days aft	—

Measure

Time frame

C-Reactive Protein. Timepoint: Measurement of C-Reactive Protein at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;White blood cell. Timepoint: Measurement of white blood cell at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;Red blood cell. Timepoint: Measurement of Red blood cell at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Hemoglobin. Timepoint: Measurement of hemoglobin at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood test.;Albumin. Timepoint: Measurement of Albumin at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Alanine aminotransferase. Timepoint: Measurement of Alanine aminotransferase at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Aspartate transaminase. Timepoint: Measurement of Aspartate transaminase at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Creatinine. Timepoint: Measurement of Creatinine at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Blood Urea Nitrogen. Timepoint: Measurement of Blood Urea Nitrogen at the beginning of the study (before the start of the study) and 40 days after the start of dandelion capsule. Method of measurement: Blood Test.;Total Bilirubin. Timepoint: Measurement of Total Bilirubin at the beginning of the study (before the start of the study) and 40 days aft

—

Secondary

Measure	Time frame
High sensitivity C-Reactive Protein. Timepoint: Before and after medication with Dandelion cap. Method of measurement: Blood Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReihaneh Tabaraie

Ghoum University of Medical Sciences

rt1356@yahoo.com+98 25 3612 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026